Identification of a new peptide for fibrosarcoma tumor targeting and imaging in vivo

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Wu, Chia Che ^a,b   Lin, Erh Hsuan ^a,c   Lee, Yu Ching ^a   Tai, Cheng Jeng ^d   Kuo, Tsu Hsiang ^a,e   Wang, Hsin Ell ^c   Luo, Tsai Yueh ^f   Fu, Ying Kai ^f   Chen, Haw Jan ^f   Sun, Ming Ding ^a   Wu, Chih Hsiung ^g   Wu, Cheng Wen ^c   Leu, Sy Jye ^h   Deng, Win Ping ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d GENOMICS RESEARCH CENTER   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; PEPTIDE DERIVATIVE; TK4 PEPTIDE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FIBRONECTIN; PEPTIDE; PEPTIDE LIBRARY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; HUMAN; HUMAN CELL; IMAGING; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PROTEIN ANALYSIS; PROTEIN TARGETING; SCINTILLATION CAMERA; TUMOR CELL; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG EFFECT; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PROTEIN BINDING; TISSUE DISTRIBUTION; TUMOR CELL LINE;

MUS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; FEMALE; FIBRONECTINS; FIBROSARCOMA; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; TISSUE DISTRIBUTION;

EID: 79251590230     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/167045     Document Type: Article

References (25)

1. Genoni M., Biraima A. M., Bode B., Shah A. C., Winkler M. B., Turina M. I., Combined resection and adjuvant therapy improves prognosis of sarcomas of the pulmonary trunk Journal of Cardiovascular Surgery 2001 42 6 829 833
2. Tsuchiya H., Tomita K., Mori Y., Asada N., Yamamoto N., Marginal excision for osteosarcoma with caffeine assisted chemotherapy Clinical Orthopaedics and Related Research 1999 358 27 35
3. Cameron M. D., Schmidt E. E., Kerkvliet N., Nadkarni K. V., Morris V. L., Groom A. C., Chambers A. F., MacDonald I. C., Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency Cancer Research 2000 60 9 2541 2546
4. Zhang J.-T., Liu Y., Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment Cancer Treatment Reviews 2007 33 8 741 756
5. Prez-Toms R., Multidrug resistance: retrospect and prospects in anti-cancer drug treatment Current Medicinal Chemistry 2006 13 16 1859 1876
6. Nogawa M., Yuasa T., Kimura S., Kuroda J., Sato K., Segawa H., Yokota A., Maekawa T., Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models Cancer Letters 2005 217 2 243 253
7. Yamamoto N., Yang M., Jiang P., Tsuchiya H., Tomita K., Moossa A. R., Hoffman R. M., Real-time GFP imaging of spontaneous HT-1080 fibrosarcoma lung metastases Clinical and Experimental Metastasis 2003 20 2 181 185
8. Marsee D. K., Shen D. H. Y., MacDonald L. R., Vadysirisack D. D., Lin X., Hinkle G., Kloos R. T., Jhiang S. M., Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography Cancer Gene Therapy 2004 11 2 121 127
9. Deng W.-P., Wu C.-C., Lee C.-C., Yang W. K., Wang H.-E., Liu R.-S., Wei H.-J., Gelovani J. G., Hwang J.-J., Yang D.-M., Fu Y.-K., Wu C.-W., Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir Journal of Nuclear Medicine 2006 47 5 877 884
10. Reubi J. C., Maecke H. R., Peptide-based probes for cancer imaging Journal of Nuclear Medicine 2008 49 11 1735 1738
11. Zitzmann S., Mier W., Schad A., Kinscherf R., Askoxylakis V., Krmer S., Altmann A., Eisenhut M., Haberkorn U., A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy Clinical Cancer Research 2005 11 1 139 146
12. Rufini V., Calcagni M. L., Baum R. P., Imaging of Neuroendocrine Tumors Seminars in Nuclear Medicine 2006 36 3 228 247
13. Schroeder R. P. J., Weerden W. M. V., Bangma C., Krenning E. P., Jong M. D., Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues Methods 2009 48 2 200 204
14. Van De Wiele C., Phonteyne P., Pauwels P., Goethals I., Van Den Broecke R., Cocquyt V., Dierckx R. A., Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry Journal of Nuclear Medicine 2008 49 2 260 264
15. Leiss M., Beckmann K., Girs A., Costell M., Fssler R., The role of integrin binding sites in fibronectin matrix assembly in vivo Current Opinion in Cell Biology 2008 20 5 502 507
16. Haubner R., Decristoforo C., Radiolabelled RGD peptides and peptidomimetics for tumour targeting Frontiers in Bioscience 2009 14 872 886
17. Brissette R., Goldstein N. I., The use of phage display peptide libraries for basic and translational research Methods in Molecular Biology 2007 383 203 213
18. Brown K. C., Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications Current Pharmaceutical Design 2010 16 9 1040 1054
19. Yang W. K., Ch'ang L. Y., Koh C. K., Myer F. E., Yang M. D., Mouse endogenous retroviral long-terminal-repeat (LTR) elements and environmental carcinogenesis Progress in nucleic acid research and molecular biology 1989 36 247 266
20. Haubner R., v 3-integrin imaging: a new approach to characterise angiogenesis? European Journal of Nuclear Medicine and Molecular Imaging 2006 33 13 S54 S63
21. Rolleman E. J., Melis M., Valkema R., Boerman O. C., Krenning E. P., de Jong M., Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues European Journal of Nuclear Medicine and Molecular Imaging 2009 1 14
22. Behr T. M., Goldenberg D. M., Becker W., Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations European Journal of Nuclear Medicine 1998 25 2 201 212
23. Komoriya A., Green L. J., Mervic M., Yamada S. S., Yamada K. M., Humphries M. J., The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine Journal of Biological Chemistry 1991 266 23 15075 15079
24. Rodenberg E. J., Pavalko F. M., Peptides derived from fibronectin type III connecting segments promote endothelial cell adhesion but not platelet adhesion: implications in tissue-engineered vascular grafts Tissue Engineering 2007 13 11 2653 2666
25. Okochi M., Nomura S., Kaga C., Honda H., Peptide array-based screening of human mesenchymal stem cell-adhesive peptides derived from fibronectin type III domain Biochemical and Biophysical Research Communications 2008 371 1 85 89